Literature DB >> 12752732

Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing.

Jae J Kim1, Jong G Kim, Dong H Kwon.   

Abstract

Antibiotic resistance among Helicobacter pylori has been increasing worldwide and has begun to affect the overall efficacy of current antibiotic regimens adversely. We examined 220 pairs of H. pylori isolates obtained from both the antrum and corpus of separate patients; 109 (50%) harbored antibiotic-resistant H. pylori: amoxicillin (0.5%), clarithromycin (5.9%), furazolidone (1.4%), metronidazole (45.5%), nitrofurantoin (1.4%), and tetracycline (6.8%). Heteroresistance among the two biopsy sites from each patient was present in 41 of the 109 patients (38%) with antibiotic resistant H. pylori (e.g. 34% with resistant strains would be misclassified as susceptible if a biopsy of the antrum alone used for antimicrobial susceptibility testing). DNA fingerprinting genotype analysis was carried out on the 41 pairs of isolates with heteroresistance. While different patients had different fingerprinting patterns, each pair of isolates showed identical or similar fingerprinting patterns. These results suggest that antibiotic-resistant H. pylori typically develop from pre-existing susceptible strain rather than coinfection with a different strain. The minor differences in genotype (degeneration of genotype) seen reflect one of the processes for development of genetic diversity in H. pylori. No biopsy single site can be considered representative for antimicrobial susceptibility testing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12752732     DOI: 10.1046/j.1523-5378.2003.00145.x

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  28 in total

1.  Occurrence of Mutations in the Antimicrobial Target Genes Related to Levofloxacin, Clarithromycin, and Amoxicillin Resistance in Helicobacter pylori Isolates from Buenos Aires City.

Authors:  Gerardo Zerbetto De Palma; Nicolas Mendiondo; Andrés Wonaga; Luis Viola; Daniela Ibarra; Esteban Campitelli; Nicolas Salim; Rodolfo Corti; Cinthia Goldman; Mariana Catalano
Journal:  Microb Drug Resist       Date:  2016-07-08       Impact factor: 3.431

2.  Second-line rescue therapy of helicobacter pylori infection.

Authors:  Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2009-11       Impact factor: 4.409

Review 3.  "Rescue" regimens after Helicobacter pylori treatment failure.

Authors:  Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-21       Impact factor: 5.742

Review 4.  Third-line rescue therapy for Helicobacter pylori infection.

Authors:  Rossella Cianci; Massimo Montalto; Franco Pandolfi; Giovan-Battista Gasbarrini; Giovanni Cammarota
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

5.  Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections.

Authors:  Julie M Morris; Alisa L Reasonover; Michael G Bruce; Dana L Bruden; Brian J McMahon; Frank D Sacco; Douglas E Berg; Alan J Parkinson
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

6.  Direct detection of Helicobacter pylori in biopsy specimens using a high-throughput multiple genetic detection system.

Authors:  Yanmei Zhang; Shiwen Wang; Binjie Hu; Fuju Zhao; Ping Xiang; Danian Ji; Fei Chen; Xiaoli Liu; Feng Yang; Yong Wu; Mimi Kong; Li Nan; Yingxin Miao; Wenrong Jiang; Yi Fang; Jinghao Zhang; Zhijun Bao; Michal A Olszewski; Hu Zhao
Journal:  Future Microbiol       Date:  2016-09-06       Impact factor: 3.165

7.  Understanding and appreciating sequential therapy for Helicobacter pylori eradication.

Authors:  David Y Graham; Emiko Rimbara
Journal:  J Clin Gastroenterol       Date:  2011-04       Impact factor: 3.062

8.  Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection.

Authors:  Michael Selgrad; Ina Tammer; Cosima Langner; Jan Bornschein; Julia Meißle; Arne Kandulski; Mariya Varbanova; Thomas Wex; Dirk Schlüter; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 9.  Attempts to enhance the eradication rate of Helicobacter pylori infection.

Authors:  Chang Seok Bang; Gwang Ho Baik
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 10.  Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.

Authors:  Aleksandra Sokic-Milutinovic; Tamara Alempijevic; Tomica Milosavljevic
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.